- likes
- 55
- comments
- 1
Post
Rare diseases are often overlooked and underfunded. Patients endure pills, injections and surgeries without ever addressing the root cause. Even as next-generation sequencing and CRISPR unlock new possibilities, the path from discovery to delivery remains fragmented. The first gene editing therapies have shown promise, but they’re only the beginning. To reach more patients, science must overcome complex scientific, regulatory and logistical barriers. That’s where Danaher comes in. We’re building a connected ecosystem that accelerates breakthroughs and brings life-changing therapies to patients sooner. Explore how we’re charting a bold path forward to turn complexity into clarity and potential into progress: https://lnkd.in/giXuTbhz